Arko Corp. (ARKO) DCF Valuation

Arko Corp. (ARKO) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Arko Corp. (ARKO) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your Arko Corp. (ARKO) valuation analysis with our state-of-the-art DCF Calculator! This Excel template comes preloaded with real ARKO data, enabling you to adjust forecasts and assumptions to accurately determine Arko Corp.'s intrinsic value.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 4,128.7 3,910.7 7,417.4 9,142.8 9,412.7 12,015.4 15,337.8 19,578.8 24,992.5 31,903.1
Revenue Growth, % 0 -5.28 89.67 23.26 2.95 27.65 27.65 27.65 27.65 27.65
EBITDA 65.2 155.7 235.7 269.5 260.4 347.3 443.3 565.9 722.3 922.1
EBITDA, % 1.58 3.98 3.18 2.95 2.77 2.89 2.89 2.89 2.89 2.89
Depreciation 62.4 74.4 97.2 101.8 127.6 172.8 220.6 281.6 359.5 458.9
Depreciation, % 1.51 1.9 1.31 1.11 1.36 1.44 1.44 1.44 1.44 1.44
EBIT 2.8 81.3 138.5 167.8 132.8 174.4 222.7 284.2 362.8 463.1
EBIT, % 0.0672126 2.08 1.87 1.83 1.41 1.45 1.45 1.45 1.45 1.45
Total Cash 32.1 293.7 310.9 300.9 222.0 435.7 556.1 709.9 906.2 1,156.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 59.8 46.9 62.3 118.1 200.3
Account Receivables, % 1.45 1.2 0.84048 1.29 2.13
Inventories 157.8 163.7 197.8 222.0 250.6 378.8 483.6 617.3 787.9 1,005.8
Inventories, % 3.82 4.19 2.67 2.43 2.66 3.15 3.15 3.15 3.15 3.15
Accounts Payable 128.8 155.7 172.9 217.4 213.7 338.4 431.9 551.4 703.8 898.4
Accounts Payable, % 3.12 3.98 2.33 2.38 2.27 2.82 2.82 2.82 2.82 2.82
Capital Expenditure -58.3 -44.7 -226.5 -98.8 -111.2 -189.1 -241.4 -308.1 -393.3 -502.0
Capital Expenditure, % -1.41 -1.14 -3.05 -1.08 -1.18 -1.57 -1.57 -1.57 -1.57 -1.57
Tax Rate, % 26.52 26.52 26.52 26.52 26.52 26.52 26.52 26.52 26.52 26.52
EBITAT 3.2 85.4 115.7 111.9 97.6 147.8 188.7 240.8 307.4 392.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -81.4 148.9 -45.9 79.4 -.5 162.3 110.9 141.5 180.6 230.6
WACC, % 4.97 4.97 4.41 3.83 4.06 4.45 4.45 4.45 4.45 4.45
PV UFCF
SUM PV UFCF 718.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 235
Terminal Value 9,613
Present Terminal Value 7,734
Enterprise Value 8,452
Net Debt 2,312
Equity Value 6,141
Diluted Shares Outstanding, MM 120
Equity Value Per Share 51.34

What You Will Get

  • Real ARKO Financial Data: Pre-filled with Arko Corp.’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Arko Corp.’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive DCF Calculator: Offers both unlevered and levered DCF valuation models tailored for Arko Corp. (ARKO).
  • WACC Estimator: Features a pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
  • Customizable Forecast Inputs: Adjust growth rates, capital expenditures, and discount rates to fit your analysis.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for Arko Corp. (ARKO).
  • Visual Dashboard and Charts: Graphical representations that succinctly highlight essential valuation metrics for straightforward analysis.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Arko Corp.’s (ARKO) financial data.
  • 2. Modify Assumptions: Adjust key variables such as growth projections, WACC, and capital investments.
  • 3. Analyze Results Immediately: The DCF model automatically computes intrinsic value and NPV based on your inputs.
  • 4. Explore Scenarios: Evaluate various forecasts to understand different valuation possibilities.
  • 5. Present with Assurance: Deliver professional valuation analyses to back your strategic decisions.

Why Choose Arko Corp. (ARKO) Calculator?

  • All-in-One Solution: Features DCF, WACC, and financial ratio assessments in a single interface.
  • Flexible Inputs: Modify yellow-highlighted fields to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes Arko Corp.’s intrinsic value and Net Present Value.
  • Preloaded Information: Historical and projected data provide a solid foundation for analysis.
  • High-Quality Standards: Perfect for financial analysts, investors, and business advisors.

Who Should Use Arko Corp. (ARKO)?

  • Finance Students: Explore financial modeling techniques and apply them to real-world scenarios.
  • Academics: Utilize industry-standard models for research and teaching purposes.
  • Investors: Validate your investment strategies and evaluate the performance of Arko Corp. (ARKO).
  • Analysts: Enhance your analysis with a flexible, pre-designed DCF model tailored for Arko Corp. (ARKO).
  • Small Business Owners: Understand the analytical frameworks used to assess larger companies like Arko Corp. (ARKO).

What the Template Contains

  • Preloaded ARKO Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.